Empower your clients to better manage their diabetes with Dexcom Continuous Glucose Monitoring (CGM)
ADVERTORIAL
Dexcom CGM – Indicated for all types of diabetes!#
Unlike fingerprick checking, CGM measures glucose levels continually, allowing people to detect potential highs or lows throughout the day and night in real-time. With Dexcom G6 CGM, the outstanding accuracy allows people with diabetes to make management decisions with no fingerpricks*.
How does CGM work?
- Sensor and Transmitter: A slim sensor is inserted via an applicator and continuously measures glucose levels just beneath the skin, and sends data wirelessly via Bluetooth to a display device through a transmitter.
- Display Device: A compatible smart device or a small touchscreen Receiver displays real-time glucose readings.^
Who can benefit from Dexcom G6?
- Indicated for anyone over two years of age with type 1, type 2 or gestational diabetes
- It works whether people are using multiple daily injections (MDI) or an insulin pump
Proven outcomes with CGM
Reduced hypoglycaemia: The predictive Urgent Low Soon alert offered by Dexcom G6 is associated with reduced hypoglycaemia, without a corresponding risk in hyperglycaemia.‡,1
HbA1c reduction: As compared fingerprick testing, use of Dexcom CGM significantly reduces HbA1c irrespective of people using multiple daily injections(MDI) or an insulin pump.2-5
Increased Time in Range: People using Dexcom CGM typically spend more time in optimal glycaemic range than those using a blood glucose meter3,4
Improved quality of life: Use of Dexcom G6 can improve quality of life and well-being.5,6
How can clients get started on Dexcom G6?
- Dexcom CGM is subsidised for Australians living with type 1 diabetes. To learn more and check eligibility criteria, click here.
- Eligible Department of Veterans’ Affairs (DVA) clients can access funded Dexcom CGM products. For more information, visit https://www.dva.gov.au/get-support/health-support/health-services/diabetes-services/diabetes-products
- For people with diabetes not eligible for subsidised CGM, they can order directly through shop.amsldiabetes.com.au
If you have a client considering CGM for the first time, consider providing them this user friendly fact sheet.
To learn more about the Dexcom G6 CGM system or get training for your clinic, visit our Dexcom Healthcare Professional website here: https://au.provider.dexcom.com/contact-us
References
#Dexcom CGM is indicated for type 1, type 2 and gestational diabetes, aged 2 years and over.
*If glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions
^ Smart device and Receiver not included with Dexcom G6 CGM System. For a list of compatible devices, visit www.dexcom.com/compatibility.
‡This predictive alert can be triggered with impending hypoglycaemia (glucose of 3.1 mmol/L or below is predicted to occur within the next 20 minutes).
1. Puhr S, et al. Diabetes Technol Ther 2019;21(4):155-8.
2. Šoupal J, et al. Diabetes Care 2019;43(1):37-43.
3. Beck, RW, et al. JAMA. 2017;317(4):371-378.
4. Welsh JB, et al. Diabetes Technol Ther. 2019;21(3):128-132
5. Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S9.
6. Olafsdottir AF, et al. Diabetes Technol Ther. 2018;20(4):274-284
© Dexcom and Dexcom G6 are registered trademarks of Dexcom, Inc. in the United States and/or other countries. Sydney, Australia. Australasian Medical & Scientific (AMSL) is a Dexcom company. MAT-2753 Rev001